-
TXG Dashboard
- Financials
- Filings
-
Holdings
- Transcripts
- ETFs
- Insider
- Institutional
- Shorts
10x Genomics (TXG)
Company Profile
Quarter (USD) | Dec 24 | Sep 24 | Jun 24 | Mar 24 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 344.07 mm | 344.07 mm | 344.07 mm | 344.07 mm | 344.07 mm | 344.07 mm |
Cash burn (monthly) | 18.03 mm | 1.27 mm | 16.61 mm | 16.21 mm | 2.25 mm | (no burn) |
Cash used (since last report) | 42.51 mm | 2.99 mm | 39.17 mm | 38.23 mm | 5.30 mm | n/a |
Cash remaining | 301.56 mm | 341.08 mm | 304.90 mm | 305.84 mm | 338.76 mm | n/a |
Runway (months of cash) | 16.7 | 269.0 | 18.4 | 18.9 | 150.6 | n/a |
13F holders | Current |
---|---|
Total holders | 271 |
Opened positions | 63 |
Closed positions | 55 |
Increased positions | 84 |
Reduced positions | 90 |
13F shares | Current |
---|---|
Total value | 1.42 tn |
Total shares | 116.19 mm |
Total puts | 132.10 k |
Total calls | 76.40 k |
Total put/call ratio | 1.7 |
Largest owners | Shares | Value |
---|---|---|
FMR | 13.45 mm | $193.21 bn |
ARK Investment Management | 11.94 mm | $171.52 bn |
Vanguard | 10.93 mm | $157.01 bn |
BlackRock | 6.77 mm | $97.22 bn |
CMTDF Sumitomo Mitsui Trust | 5.71 mm | $82.05 bn |
Nikko Asset Management Americas | 5.71 mm | $82.05 bn |
Venrock Associates VI | 4.83 mm | $0.00 |
MS Morgan Stanley | 3.93 mm | $56.37 bn |
Ra Capital Management | 3.28 mm | $47.09 bn |
Meritech Capital Partners V | 2.58 mm | $365.47 mm |
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
4 Mar 25 | Saxonov Serge | Class A Common Stock | Option exercise | Acquire M | No | No | 1.2 | 50,000 | 60.00 k | 921,540 |
4 Mar 25 | Saxonov Serge | Stock Option Class A Common Stock | Option exercise | Dispose M | No | No | 1.2 | 50,000 | 60.00 k | 17,463 |
28 Feb 25 | Saxonov Serge | Class A Common Stock | Sell | Dispose S | No | Yes | 10.6262 | 7,942 | 84.39 k | 871,540 |
24 Feb 25 | Saxonov Serge | Class A Common Stock | Sell | Dispose S | No | No | 11.0656 | 5,092 | 56.35 k | 879,482 |
24 Feb 25 | Hindson Benjamin J. | Class A Common Stock | Sell | Dispose S | No | No | 11.0656 | 4,573 | 50.60 k | 335,324 |
21 Feb 25 | Alan Mateo | Class A Common Stock | Buy | Acquire P | No | No | 11.1393 | 40,000 | 445.57 k | 61,691 |
23 Dec 24 | Saxonov Serge | Class A Common Stock | Option exercise | Acquire M | No | No | 1.2 | 12,000 | 14.40 k | 884,574 |
23 Dec 24 | Saxonov Serge | Stock Option Class A Common Stock | Option exercise | Dispose M | No | No | 1.2 | 12,000 | 14.40 k | 67,463 |